1. science
2. medicine
3. surgery

TH
95
AATS
DAI LY
NEW S
2015
A PRIL 25-29, 2015 • W ASHINGTON S TATE C ONVENTION C ENTER • S EATTLE , WA
MONDAY EDITION
MONDAY
6:30 a.m.
Maintenance of Certification Information
Breakfast
7:20 a.m.
Business Session (AATS Members Only)
7:30 a.m.
Plenary Scientific Session
9:45 a.m.
Basic Science
Lecture
Donald E. Ingber,
MD, PhD
Wyss Institute for
Biologically Inspired
Engineering
DR. INGBER
11:05 a.m.
New Member Induction
11:25 a.m.
PRESIDENTIAL ADDRESS: “Technological
Innovation in Cardiothoracic Surgery: A
Pragmatist’s Approach”
Pedro J. del Nido, MD
2:00 p.m. – 5:35 p.m.
Adult Cardiac Surgery
Simultaneous Scientific Session
2:00 p.m. – 5:35 p.m.
Congenital Heart Disease
Simultaneous Scientific Session
2:00 p.m. – 5:35 p.m.
General Thoracic Surgery
Simultaneous Scientific Session
Continued on page 4
Presidential Address
Monday, April 27
11:25 a.m.
DR. DEL NIDO
“Technological
Innovation in
Cardiothoracic
Surgery: A
Pragmatist’s
Approach”
Pedro J. del Nido,
MD
Boston Children’s
Hospital
Cardiac Skills Course Looked to Best Choices
A
unique feature of the Saturday’s
Adult Cardiac Skills Course presentations, organized by course
chairs, Lars G. Svensson, MD, Cleveland Clinic, and Michael A. Borger,
MD, Columbia University, was the
theme of “How I Would Like My [insert procedure here] Done.”
For example, the question of “How
I Would Like My Transapical Valve
Inserted” was addressed by Vinod H.
Thourani, MD, Emory University.
With regard to types of transcatheter aortic valve replacement (TAVR),
“for me I do a little bit of everything,
open and transcatheter,” said Dr. Thourani. “In 2015, the access alternatives
are many,” he said pointing out transfemoral, transapical, transaortic, and
even transcaval as some of the varied
approaches for valve replacement.
“Transfemoral is creeping up, and
by end of next year, 80% to 90% of all
cases will be transfemoral.” He pointed
out that this means that to keep up,
cardiac surgeons must become comfortable with doing transfemoral.
“Comparing transapical and trans-
Vinod H. Thourani, MD, addressed
TAVR access alternatives.
aortic, transapical does a little bit better
than transaortic when you look at 3-,
30-day, 6-month, and 1-year data.” And
this is across thousands of patients in
the United States, he added.
He demonstrated the techniques he
used to perform transapical and then
concluded with a warning to the audi-
ence: “If you don’t know transcatheter
access, you better learn it, because
mitral valves are coming soon, and this
is something you are going to want to
know how to do.”
In his talk, “How I Would Like My
Direct Aortic Valve Inserted,” Michael
J. Reardon, MD, Methodist DeBakey
Heart Center, discussed the increasing
likelihood of using TAVR in patients
with symptomatic severe aortic stenosis
who are at increased surgical risk and
how it is imperative that cardiac surgeons play a role in the development
and direction of this therapy.
Dr. Reardon cited how, in the CoreValve trial, 17% of cases could not be
accomplished using a transfemoral
route and access via a surgical approach
was necessary. Direct aortic access for
TAVR was one option in which cardiac
surgeons took the lead. He discussed
the selection process and technical
aspects of direct aortic access for the
cardiac surgeon interested in TAVR,
referring to published outcomes and
technical aspects of this approach.
Continued on page 4
Innovation in Focus at Cardiothoracic Ethics Forum
C
ourse co-chairs, Martin F.
McKneally, MD, University
of Toronto, and Robert M.
Sade, MD, Medical University
of South Carolina, presented a
day-long program that focused
on the ethical issues faced by
practicing surgeons, including
issues of informed consent,
organ donation and transplant,
and a debate on the appropriateness of live-broadcast surgery as
a training tool.
In a special section on “Innovation and Research,” three speakers dealt with the thorny issues
involved in balancing the ethical
aspects of patient care with the
need to develop improved meth-
odology and devices.
In his presentation, “How is
innovation different from research?” Paul W. Fedak, MD,
University of Calgary, pointed
out that research was primarily
systematic and addressed a scientific question, whereas innovation proceeded in incremental
steps in order to improve accepted practice based on observation.
And very importantly, research
is carefully regulated and does not
allow for much leeway, compared
with innovation. But this is not
to say, however, that innovation
should not somehow be validated
and monitored, Dr. Fedak said.
Continued on page 4
Paul W. Fedak, MD, spoke on the differences
between research and innovation.
DELIVERING MORE INNOVATION
Bio-Medicus
™
NEXTGEN FEMORAL CANNULAE
NEW
Designed for Insertability.
We know insertability is important to you — and that’s why our
Bio-Medicus™ NextGen Femoral Cannulae are engineered for smooth
transitions. Patented fingerlet supports are formed into the tapered
tip to create an even smoother transition between the introducer
and thin cannula wall. Feel the difference!
Stop by Medtronic booth 537 to
see the new Bio-Medicus NextGen.
www.findyourideal.medtronic.com
Innovating for life.
Important Safety Information is available in Medtronic booth,
www.MedtronicMICS.com and in applicable Instructions for Use.
201506323EN.indd 1
Trademarks may be registered and are the property of their respective owners.
©2015 Medtronic. All rights reserved. UC201506323 EN 03/2015
4/6/15 9:22 AM
4 AATS 95TH ANNUAL MEETING
Continued from page 1
2:00 p.m. – 5:35 p.m.
Perioperative Care
Simultaneous Scientific Session
5:00 p.m. – 6:30 p.m.
18th Annual C. Walton Lillehei Resident
Forum
5:00 p.m. – 6:30 p.m.
Integrating Advanced Imaging in Planning
Interventions: A Case-Based Interactive
Expert Panel Review
A PRIL 25-29, 2015
Cardiac Skills continued from page 1
Transapical and direct aortic implantation are the two most direct methods
of access for TAVR, said Dr. Reardon.
Neither of these are limited by peripheral vascular status, sheath size, or aortic angle, and both avoid passing device
across the arch, and both allow precise
deployment due to proximity.
5:00 p.m. – 6:00 p.m.
Functional MR: A Surgical Disease? New
Surgical and Interventional Paradigms for
Treatment
TUESDAY
7:00 a.m. – 8:40 a.m.
Cardiac Surgery Forum
7:00 a.m. – 8:40 a.m.
General Thoracic Surgery Forum
7:00 a.m. – 8:40 a.m.
Adult Cardiac Emerging Technology and
Techniques Forum NEW!
7:00 a.m. – 8:40 a.m.
General Thoracic Emerging Technology and
Techniques Forum NEW!
7:00 a.m. – 8:40 a.m.
Video Session
7:00 a.m. – 8:40 a.m.
VAD/ECMO Session NEW!
8:45 a.m. – 12:30 p.m.
Plenary Scientific Session
11:40 p.m. – 12:30 p.m.
HONORED GUEST LECTURE
Three Ideas About Changing Things
Col. Casey Haskins
12:30 p.m. – 2:00 p.m.
Lunch in the Exhibit Hall
12:45 p.m. – 2:00 p.m.
Moderated Poster Competition
Michael J. Reardon, MD, spoke about
TAVR in high surgical risk patients.
Specifically, direct access has a
number of additional advantages for
the cardiac surgeon. It can be done
without a thoracotomy, leads to less
pulmonary impairment, and requires
no injury to the myocardium. In
addition, the aorta moves much less
•
W ASHINGTON S TATE C ONVENTION C ENTER
•
S EATTLE , WA
than the cardiac apex, and bleeding
around the sheath is not a problem.
It works for both available valves,
and aortic cannulation is something
which all cardiac surgeons are routinely familiar with.
He discussed the excellent results
of direct aortic access TAVR, how
the technology is continuing to
develop, and that a new iteration of
the procedure provides a promising
minimally invasive percutaneous surgical TAVR system using suprasternal
access. “I think as time goes on, the
way I would like my aortic valve is
Gregory P. Fontana, MD, discussed the
done without opening my chest at
advantages of self-expanding valves.
all,” Dr. Reardon concluded.
In his talk, “How I Would Like a
Self-Expanding Valve Inserted Includ- ral first, ” he said. He would like coning Subclavain Backup,” Gregory P.
scious sedation, which is something
Fontana, MD, Lenox Hill Hospital,
that is very easy to do with self-expanddiscussed the advantages of using
ing valves and in many centers in Euself-expanding valves.
rope, over 90% of cases are done with
Current valves are all fully recapthe patients awake with local or with
turable, retrievable, and resheathable.
conscious sedation. “I think there are
In addition, there are self-expanding
some clear advantages to the technolovalves useable for each of the access
gy and the technique that make it safer
options. “Results have been so good,
than other platforms,” he concluded.
leading to greater expansion into
Other presentations throughout the
lower-risk patients,” said Dr. Fonday focused on other types of valve
tana. He stressed the need to rely on
repair, treatment of aortic arch dissecsophisticated imaging technology to
tions, and thoracic artery aneurysms,
determine which access is best, which all following the same theme, even
prosthesis is best, and which size
including styles of coronary artery
would be ideal.
bypass grafting and ventricle septal
“Personally, I would like transfemodefect repair.
2:00 p.m. – 5:35 p.m.
Adult Cardiac Surgery
Simultaneous Scientific Session
Ethics continued from page 1
2:00 p.m. – 5:35 p.m.
Because medicine is a self-regulating profession, this implies an ethical
standard, said Dr. Fedak, wherein
practitioners must look to themselves
to provide the appropriate oversight
of innovation in the absence of external monitoring. This standard is
important for the safety of patients,
but also for the validation of results.
He stressed the need for professional
oversight, pointing out that it should
be seen as a protective guard rail, and
not a stumbling block.
Congential Heart Disease Surgery
Simultaneous Scientific Session
2:00 p.m. – 5:35 p.m.
General Thoracic Surgery
Simultaneous Scientific Session
2:00 p.m. – 5:35 p.m.
Aortic/Endovascular Surgry
Simultaneous Scientific Session
5:35 p.m. – 6:15 p.m
Executive Session (AATS Members only)
7:00 p.m. – 10:00 p.m.
AATS Attendee Reception at The Museum
of Flight
WEDNESDAY
7:00 a.m. – 9:35 a.m.
Adult Cardiac Surgery
Simultaneous Scientific Session
7:00 a.m. – 9:35 a.m.
Congenital Heart Disease
Simultaneous Scientific Session
7:00 a.m. – 9:35 p.m.
General Thoracic Surgery
Simultaneous Scientific Session
9:45 a.m. – 11:15 a.m.
Adult Cardiac Masters of Surgery Video
Session
9:45 a.m. – 11:15 a.m.
Congenital Heart Disease Masters of
Surgery Video Session
9:45 a.m. – 11:15 a.m.
General Thoracic Masters of Surgery Video
Session
Richard I. Whyte, MD, discussed
oversight of innovation.
Richard I. Whyte, MD, of Harvard
Medical School, carried on with this
theme, in tackling the controversial
topic of “Is oversight for innovation
adequate?” The simple answer, according to Dr. Whyte is “it depends,” citing
the profound differences of opinion
among groups about balancing innovation with regulation.
In her presentation “Are sham
operations and placebos justifiable
in research?” Leslie J. Kohman, MD,
SUNY Upstate Medical University,
addressed the real quandary of dealing with the placebo effect in surgical
trials. While starch or sugar pills may
be a harmless placebo in trials of
new medicines, performing sham or
placebo operations has inescapable
real risks due to the necessary invasiveness of any procedure capable of
masking the fact that a completed
surgical treatment was not performed.
Yet there can be extremely important results from such surgical placebo
trials. Dr. Kohman discussed several
cases where well-accepted practices
were found to be ineffective when
finally compared with authentic
surgical placebo controls, including
arthroscopic knee surgery and lavage.
Of great relevance to cardiothoracic
Leslie J. Kohman, MD, considered the
issues surrounding sham operations.
surgeons is the case of internal mammary artery ligation, which was used
very frequently in the middle of the
20th century to treat angina, but was
found to be no better than a fake incision.
Dr. Kohman went on to discuss
how the choice to do a placebo operation in a trial had important ethical
considerations, including the need
for authentic equipoise as to the validity of the treatment being studied,
a careful balance of risks, and a firm
assurance of the scientific validity of
the study.
A PRIL 25-29, 2015
S
•
W ASHINGTON S TATE C ONVENTION C ENTER
•
S EATTLE , WA
AATS 95TH ANNUAL MEETING
The Challenges of Dealing With End-Stage Organ Failure
aturday’s “Optimal Strategies for
End-Stage Organ Failure” focused on
a continuum of relevant topics from
the technical to the ethical, including the
financial and regulatory aspects of support
and transplantation for end-stage heart
and lung disease.
In his presentation, “ECMO vs. CPB for
Intraoperative Support: How and What
Do You Choose?” Shaf Keshavjee, MD,
Toronto General Hospital, discussed how
extracorporeal membrane oxygenation
(ECMO) has evolved from a relatively
rare technique to a valid competitor to
cardiopulmonary bypass, such that, at his
institution, ECMO is now the standard
support method for organ transplant operations.
R. Duane Davis, Jr., MD, Duke
University, course co-chair, discussed
the thorny issue of “Transplant
Regulation and Finance: What You
Really Need to Know.” He discussed
how transplant programs can be quite
profitable, but they have very strict
requirements in volume and concern
for expenses if there is to be long-term
R. Duane Davis, Jr., MD, said cost issues
are critical to transplant programs.
viability after a high initial outlay.
He also discussed how the Centers for
Medicare & Medicaid Services (CMS)
and United Network for Organ Sharing
(UNOS) have different regulatory perspectives. CMS, in particular, uses 1-year
patient and graft survival as a flagging
mechanism with the following criteria:
Observed minus Expected greater than
3; Observed/Expected greater than 1.5;
and a one-sided P-value less than .05. At
the conditional level, the program meets
flagging criteria two times during five
consecutive reporting periods, and significant consequences ensue.
To discuss these consequences of
when things go wrong and regulators
take notice, Christine L. Lau, MD, University of Virginia, presented “CMS/
UNOS is Calling: How to Emerge
from Regulatory Hell.”
She spoke from the perspective
Shaf Keshavjee, MD, said ECMO is
now an accepted, standard approach.
of the experiences she and her colleagues had at UVA. “Our program
went through a series of restructurings
because of deficiencies that led us to
be flagged several years ago,” said Dr.
Lau. “But after refocusing and making
significant changes, we now have the
best national outcomes (100% 1-year
survivals for our lung transplant program).”
At UVA, all the solid organ programs
have been flagged in the past, and major quality changes were instituted as
a result. In the case of the heart and
lung programs, CMS offered a Systems
Improvement Agreement (SIA) with
the agency which required significant
teamwork to work through. After
emerging from their SIAs, currently
both the lung and heart programs are
outperforming expected results.
The SIA is one mechanism to strong-
ly encourage a transplant program to
improve quality, according to Dr. Lau.
It is a legal and binding document,
which is done in concert with, and in
negotiation with, CMS. SIA hospital
responsibilities include contracting
with an independent, on-site consultant, having an independent peer
review (IPR) conducted, performing a
comparative effectiveness analysis, and
creating an action plan from the IPR.
Cooperation/consultation with CMS
and data submission must be maintained, including reporting any death
or graft failure within 24 hours. And ultimately, a “lessons learned” document
must be filed, said Dr. Lau.
Today, UVA has successfully learned
from its past CMS scrutiny. Through
the process the university has better
systems in place, has modernized and
made significant changes, and the
Christine L. Lau, MD, discussed CMS
regulations for transplant programs.
patients are much better off, said Dr.
Lau. The future of lung (and heart)
transplantation at UVA is bright, Dr.
Lau concluded.
Honored Guest Lecturer: Col. Casey Haskins,
Tuesday, 11:40 a.m.
C
olonel Casey Haskins
will share his expertise
on helping leaders
build innovative, creative
environments and attitudes.
In his army career, he has
commanded at every level
from platoon through brigade and has served in staff
positions from battalion
COL. HASKINS
through theater army. An
accomplished military officer, faculty member at West
Point Academy and founder
of the consulting firm, BLK
SHP INNOVATIONS,
Col. Haskins will focus on
strategies that facilitate the
discovery and reinvention
of solutions to challenging
problems.
5
6 AATS 95TH ANNUAL MEETING
A PRIL 25-29, 2015
•
W ASHINGTON S TATE C ONVENTION C ENTER
•
S EATTLE , WA
New Developments in General Thoracic Surgery
S
aturday’s General Thoracic Skills
Course, organized by Yolonda Colson, MD, and co-chaired by Ara
Vaporciyan, MD, and Pascal Thomas,
MD, highlighted the new developments in three broad areas: minimally
invasive approaches to the diagnosis
and staging of lung lesions, treatment
of non-palpable lung lesions, and
endoscopic diagnosis and treatment
of esophageal disease. All the presentations were designed to highlight a
specific technique that is either in the
early phases of adoption or a new innovation that is still moving towards
implementation.
In the afternoon session, Dr. Vaporciyan introduced the discussion
of dealing with small lung nodules
and new techniques to identify these
lesions more accurately interaoperatively and to allow targeted excision
for diagnosis and treatment. For
example, Richard Finley, MD, University of British Columbia, discussed
the preoperative use of computed
tomography – guided microcoils for
the localization of small peripheral
pulmonary nodules.
Because computed tomographic
(CT) screening has increased the
number of small undiagnosed peripheral lung nodules, there is an in-
Ara Vaporciyan, MD, introduced the
topic of lung nodules.
Richard Finley, MD, took on the topic
of CT-guided microcoils.
K. Robert Shen, MD, spoke on nuclearguided intraoperative identification.
creased need for thoracic surgeons to
evaluate these nodules in order to rule
out primary lung cancer, metastatic
disease to the lungs, or in some cases,
to distinguish between primary lung
cancer and metastatic cancer to the
lung in patients at high risk for both,
Dr. Finley said. Surgical resection of
the entire nodule eliminates sampling
errors. Use of microcoils allows this.
The nodule and coil are completely
excised using endostaplers under thoracoscopic and fluoroscopic guidance.
“The platinum microcoil localization technique can be safely em-
ployed with currently available CT
resources and allows video-assisted
thoracoscopic (VATS) diagnostic
wedge resections of small peripheral
lung nodules without thoracotomy by
improving visualization and localization,” Dr. Finley concluded.
K. Robert Shen, MD, Mayo Clinic,
discussed nuclear-guided intraoperative identification. “Several years
ago, we modified a technique utilizing CT-guided radiotracer injection
followed by intraoperative thoracoscopic radioprobe localization as the
preferred method for finding nodules
that we anticipate preoperatively will
be difficult to see or palpate,” said Dr.
Shen.
He reviewed the experience of using
this technique on over 200 cases at the
Mayo Clinic since October 2008. The
indications for surgery have ruled out
lung cancer in 44%, ruled out metastatic lung disease in 40%, and ruled out
lung cancer versus metastatic lung disease in 14%. Of the nodules we have
removed, 46% have been lung cancer,
39% have been metastatic lesions, and
only 15% have been benign nodules,
according to Dr. Shen.
Lunch with the
Legends
Download the AATS Annual
Meeting Mobile App!
T
A
ttendees had the opportunity to have lunch
with three luminaries in the field of cardiothoracic surgery. Tirone E. David, MD, Marc
R. de Leval, MD, and Jean Deslauriers, MD, have
made historic contributions to the profession.
These luncheons were a tribute to their life’s work
and provided them an opportunity to share their
expertise and wisdom.
Marc R. de Leval, MD
Tirone E. David, MD
Jean Deslauriers, MD
he 2015 AATS Annual
Meeting Mobile App will
offer attendees the full AATS
meeting experience right in the
palm of their hand. Meeting
attendees will be able to access
every detail of the meeting, including the scientific program,
speakers, exhibitors, meeting locations, attendees, and Seattle.
The app will encourage users
to add their own personalization,
including a My Schedule, My
Notes, and My Briefcase, where
you can store your favorite documents for future reference.
Additional features include:
• A complete up-to-day schedule of what’s happening.
• Interactive Exhibit Floor.
• Floor plans for the Convention Center and hotel
Meeting Rooms.
• Exhibitor List, with company description, contact
information, and booth location.
• Info Booth with general information on the Annual Meeting.
Available through iTunes Store, and Android Market.
8 AATS 95TH ANNUAL MEETING
A PRIL 25-29, 2015
•
W ASHINGTON S TATE C ONVENTION C ENTER
•
S EATTLE , WA
M
ore than 1,100 cardiologists
and cardiothoracic surgeons
converged here on Thursday
and Friday to deliberate and debate
the latest findings in mitral valve surgery at the third annual Mitral Conclave of the American Association
for Thoracic Surgery, which officially
David Adams, MD, welcomed
attendees from 61 countries.
kicks off AATS Week 2015.
David Adams, MD, program director of Mount Sinai Health System,
noted that attendees represented 61
different countries, “so I really think
this has become an international
event.”
The meeting comprised plenary
sessions that featured debates and
discussions on basics of mitral valve
repair, principles of mitral valve
replacement, transcatheter therapy,
decision making in mitral valve repair and replacement, ischemic mitral valve regurgitation and dealing
with major complications.
In the Conclave Special Lecture,
Rick Nishimura, MD, of Mayo
Clinic explored the 2014 American
Heart Association/American College of Cardiology Guideline for the
Management of Patients With Valvular Heart Disease (J. Thorac. Cardiovasc. Surg. 2014;148:e1-e132).
The practice guidelines aim to
structure the decision-making process for surgeons and cardiologists
by describing a range of acceptable approaches to the diagnosis,
management and prevention of
specific cardiovascular diseases, Dr.
Nishimura said.
“The guidelines attempt to define
practices that meet the needs of
most patients in most circumstances,” he said.
The conclave also provided more
than 18 hours of smaller breakout
sessions, gatherings that allowed for
give-and-take with the internationally recognized faculty, among them
Rüdiger Lange, MD, of the German
Heart Center, who participated in
the breakout on mitral valve surgery
in young patients, and Yukikatsu
Okada, MD, of Midori Hospital, an
expert on mitral valve regurgitation
after valve repair.
Breakout sessions concentrated
on pediatric mitral valve disease,
degenerative valve disease and rheumatic valve disease.
Moderated panel discussions tackled the decision making involved in
deciding when to operate or employ
watchful waiting; the indications for
mitral valve replacement vs. repair, as
well as re-replacement; mitral valve
surgery in children and transcatheter
mitral valve replacement.
Expert technique video sessions
focused on complex valve repair and
management of the posterior leaflet
and posterior annulus and anterior
leaflet.
New for this year were sponsored
lunch symposia each day. “These are
great sessions designed for discussion,” Dr. Adams said. The symposia
addressed the role of replacement
vs. repair for severe ischemic mitral regurgitation and a discussion
exploring the surgeon’s role in the
future of transcatheter mitral valve
replacement.
W. Randolph Chitwood, Jr., MD,
PHOTOS ©AATS/B EN G ANCSOS
Third Annual Mitral Conclave Draws an International Audience
Michael J. Mack, MD; Rakesh M. Suri, MD; Saibal Kar, MD; Ottavio R. Alfieri, MD;
and Joerg Seeburger, MD, participated in a panel on valve repair.
of East Carolina University delivered the Conclave Honored Lecture,
“A Journey in Mitral Valve Surgery,”
in which he explored the roots of
Robert A. Dion, MD, spoke on current
work on ischemic mitral regurgitation.
modern mitral valve repair and replacement. Dr. Adams presented
Dr. Chitwood with the AATS Mitral
Conclave achievement award.
“This really is quite a program,”
AATS president Pedro del Nido,
MD, noted during the opening
session. “It’s an amazing accomplishment considering that it’s a
relatively new effort, but more importantly, I think this structure, this
idea of having a truly international
meeting to focus on a particular area
that’s of critical importance to our
specialty, is a way that we’re going to
be teaching ourselves and educating
ourselves for the future.”
In his opening remarks, Dr. Adams explained how the meeting
first came about. “It was seven years
ago when Thoralf Sundt and I were
having a cup of coffee—he was secretary of AATS at the time—and
we talked about an idea of trying to
have a specialty meeting in microsurgery to really unite the field and
bring everyone together.
“We could learn from each other
and get rid of the different camps
and try to really advance the field
forward,” he said.
Twenty-two featured abstracts
were presented. They focused on
how transcatheter mitral valve repair
can influence surgeon behavior, patient selection and reimbursement,
and the reproducibility of minimally
invasive mitral valve repair with artificial chords, among other topics.
“This program really is about interchange,” Dr. Adams aid. “We’re
going to have lots of access to everybody up here, and of course we want
to learn from you as well.”
Bring the AATS
Annual Meeting
Home
M
ost presentations from the
2015 AATS Annual Meeting will be available on the
AATS website, www.aats.org, immediately following the meeting.
Re-visit a session, share with
your colleagues, or view a presentation you may have missed.
This year’s Mitral Valve Conclave had over 1,100 attendees,
190 e-posters, 53 presentations, and 22 featured abstracts.
Francis C. Wells, MD, of Papworth Hospital, Cambridge,
spoke on mitral value repair and leaflet repair.
A PRIL 25-29, 2015
•
W ASHINGTON S TATE C ONVENTION C ENTER
Allied Health Symposium –
Charting the Best Patient Care
S
aturday’s Allied Health Personnel
Symposium gave presentations focusing on how to provide the best
and safest care to cardiothoracic surgery
patients from preop to OR to ICU.
The value of controlling postoperative glucose levels has been controver-
with emergent extubation and how
many lethal effects occurred from misguided attempts to replace the tube.
In an eye-opening presentation,
“Risk Factors, Management and Outcomes of Neurological Dysfunction
after CT Surgery: ICU Delirium to
Gorav Ailawadi, MD, discussed
glucose control in CABG patients.
Sudish C. Murthy, MD, reviewed the
issue of airway loss in the OR.
sial, and studies have shown conflicting
results in patient outcomes between
strict and liberal control measures.
The issue of glucose control is an
important one, because 37% of CABG
patients today have diabetes and 50%
of patients develop postoperative
hyperglycemia, according to Gorav
Ailawadi, MD, University of Virginia
Health System. He presented data
showing that, at his institution, moderate control was better than either strict
or liberal glucose control for cardiac
surgery patients.
Moderate control led to less hypoglycemia, less prolonged ventilation, a
2-day–shorter length of stay, 30% lower major complication rate, and 40%
lower odds of death, he said.
“Although glucose control is critical,
the most optimal goals are unknown.
Clearly, the SCIP measures were artificial and now have been suspended. We
have created a dedicated cardiovascular
diabetes consult service run by midlevel providers and endocrinologists,
which has resulted in outstanding glucose control in our cardiac patients,”
said Dr. Ailawadi.
“The loss of an airway is an absolutely devastating complication and in
many hospitals is considered a ‘never
event,’ ” said Sudish C. Murthy, MD,
Cleveland Clinic, in his talk “Emergent
Management of Airway Complications
in the OR and ICU.” He pointed out
the critical need to monitor tracheal
tubes in patients at all times, how ICUs
were woefully underprepared to deal
Stroke,” Sidney Levitsky, MD, of Beth
Israel Deaconess Medical Center, detailed how much worse the incidence
of stroke and neurological problems
is when patients are closely evaluated
using modern techniques and not just
the generalized assessment typically
performed by cardiologists and cardiothoracic surgeons.
“We’re underepresenting and underdefining neurologic dysfunction,
not picking up enough stroke,” he said.
Sidney Levitsky, MD, spoke about
postop neurologic dysfunction.
“To reduce the risk factors we really
have to focus on the patient-related risk
factors such as degree of cardiovascular
atherosclerosis, rather than looking at
procedure variables,” he concluded.
The symposium was moderated by
Michael A. Acker, MD, University of
Pennsylvania.
•
S EATTLE , WA
AATS 95TH ANNUAL MEETING
9
10 AATS 95TH ANNUAL MEETING
A PRIL 25-29, 2015
•
W ASHINGTON S TATE C ONVENTION C ENTER
•
S EATTLE , WA
2015 AATS Annual Meeting Exhibitors
L
L
L
E XIT
AATS Exhibit Hall Hours
SCIENTIFIC SESSIONS
N9
N10
WELCOME
CENTER
L
TO FIRE
E XITS
Monday April 27
9:00 a.m. – 4:30 p.m.
Tuesday April 28
9:00 a.m. – 4:30 p.m.
N13
C YBER C AF E
N12
L
NO BOO THS
THIS AR EA
E XIT
E XIT
E XIT
G AT E 5
G AT E 7
L
E XIT
G AT E 4
L
F&B
140
138
136
134
132
FUTURE
MEETINGS
343
Edwards
Lifesciences
Medtronic
MAQUET
Medical
337 Systems
TOP G UN
9'
POSTERS
537
737
531
431
Medtronic
Customer
Experience
Center
On-X Life
Technologies
333
331
F& B
S TAGE
SYMPOSIA
WALL
FHC
FE
F
THE ATER # 1
142
LEARNING
CENTER
ENTRANCE
144
Association Booths
LE
TO SOUTH LOB B Y
CHARGING
STATION
730
831
Medtronic
Customer
Experience
Center
931
48 POSTER BOARDS
128
C WF
P UB LIC
P HO NE S
RO O M 401
2016
BOOTH
S ELEC TION
723
520
1023
1123
WO MEN
1017 1116
1117
1011 1110
1111
919
516
Companies highlighted in orange are
advertisers of the AATS Daily News
C WF
WO MEN
917
MEN
P UB LIC
P HO NE S
ME N
617
517
Kapp
Surgical
512
512Instrument
817
717
1016
COFFEE
813
511
611
711
709
508
810
808
811
809
910
909
1008
907
1006
908
Admedus
DO WN
UP
706
505
E XIT
604
605
704
705
804
805
904
COFFEE
501 600 601 603 700
ENTRANCE
P UB LIC
P HO NE S
504
2310 S Miami Blvd., Suite 240,
Durham, NC 27703
www.aemedical.com
Abbott Vascular
Acelity (KCI)
1325
12930 IH 10 W., San Antonio, TX 78249
www.acelity.com
A&E Medical products include MYO/
Wire® temporary pacing wires, MYO/Wire
II sternum wires, MYO/Punch rotating
surgical punch, MYO/Lead disposable patient cable and DoubleWire high strength
sternal closure system.
511
3200 Lakeside Drive, Santa Clara, CA 95054
www.abbottvascular.com
MitraClip is the world’s first transcatheter
mitral valve repair therapy available, providing an option for select patients with
degenerative mitral regurgitation.
1105
1005 1104
1213 1312
1313
1211 1310
1311
1209 1308
1309
1207 1306
1307
1205 1304
1305
504
C OATS
A & E Medical Corporation
1325
THE ATER # 2
G AT E 9
E XIT
1225 1324
S TAGE
523
1327
C OFFEE
S HOW
MAN AG EMENT
O FF IC E
1227 1326
Acelity provides a trusted and complementary portfolio of advanced wound therapeutics and regenerative medicine from
KCI, LifeCell and Systagenix.
Acute Innovations
21421 NW Jacobson Road, Suite 700,
Hillsboro, OR 97124
www.acuteinnovations.com
1017
Furthering their reputation as a leader in
the thoracic industry, ACUTE Innovations® continues to make advancements in
chest-wall stabilization technology. Stop by
our training booth #1017 to learn about
ACUTE’s NEW and exciting cutting-edge
products: the RibLoc® U Plus Chest Wall
ENTRANCE
P UB LIC
P HO NE S
F
Plating System and the AcuTie® II Sternum
Closure System.
Admedus
1105
8400 Normandale Lake Blvd, Suite 920,
Minneapolis, MN, 55437
www.admedus.com
Admedus, a global healthcare group, is working with renowned medical leaders to bring
new medical technologies to market. CardioCel®, a cardiovascular scaffold, is the first of
our ADAPT® tissue engineered bio-implants
and is being used by surgeons to repair simple
and complex cardiac defects.
Advanced Cardiothoracic
Consultants, LLC
1310
12155 Golden Bluff Court, Indianapolis, IN
46236
www.actc4solutions.com
1200 1201 1300 1301 1400 1303
F
U P TO 5
Utilizing over 40 years of clinical expertise
in cardiothoracic, thoracic transplant/
organ replacement, and advanced heart
failure ACTC can evaluate financial and
clinical aspects for programs to increase
efficiencies. Whether a new or well established program, hospital, or insurer let
ACTC assist you in maintaining financial
viability and sustaining growth in today’s
challenging healthcare market.
AtriCure, Inc.
817
6217 Central Park Drive, West Chester, OH
45069
www.atricure.com
AtriCure is intent on reducing the global
Afib epidemic and healing the lives of those
affected through clinical science, education
and innovation. We are a leading Afib solu-
A PRIL 25-29, 2015
•
W ASHINGTON S TATE C ONVENTION C ENTER
tions partner with the only FDA-approved
surgical treatment for Afib and most widely implanted occlusion device for left atrial
appendage management.
Bard Davol
617
100 Crossings Boulevard, Warwick, RI 02886
www.davol.com
BARD is the market leader in comprehensive soft tissue reconstruction. In addition
to this extensive suite of products, or BioSurgery franchise is delivering a growing
line of sealants and hemostatic products
to complement surgical techniques across
thoracic, cardiovascular, and other surgical
specialties.
BFW, Inc.
917
2307 River Road, #103, Louisville, KY 40206
www.bfwinc.com
Surgical headlight innovation is BFW.
From its new Ambrose™ and Montauk™
portable LED systems, to introducing solid-state plasma fiber-optic illumination, to
pioneering coaxial High-Definition headlight video imaging, BFW’s universal reputation for quality, personalized service and
hi-tech leadership is second to none.
Biomet Microfixation
804
1520 Tradeport Drive, Jacksonville, FL 32218
www.biomet.com/microfixation
Biomet Microfixation is a leading global
healthcare provider of orthopedic products.
Our thoracic portfolio includes the Pectus
Bar for repair of Pectus Excavatum and
the SternaLock Blu Primary Closure System for sternal closure. The Blu System
aligns and stabilizes the sternum after
sternotomy and enables easier closure after
minimally invasive access.
Bolton Medical Inc.
1213
799 International Pkwy, Sunrise, FL 33325
www.boltonmedical.com
Bolton Medical is a subsidiary of the WerfenLife Company. WerfenLife is an international company that manufactures and
distributes medical diagnostic solutions
and medical devices worldwide. Bolton
Medical sells endovascular therapies for
thoracic repair, such as Relay Thoracic
Stent-Graft in both U.S. and International
markets and Relay NBS (non-bare stent)
in International markets.
CardiacAssist, Inc.
1207
240 Alpha Drive, Pittsburgh, PA 15238
www.cardiacassist.com
CardiacAssist, inventor of the TandemHeart® Extracorporeal Circulatory
Support System, offers versatile MCS treatment options. While we’re best known for
our Left Ventricular Support platform, we
recently launched a line of Arterial Cannulae, and the PROTEK Duo™ Veno-Venous
dual lumen cannula. Stop by our booth to
learn more.
Cardiovascular Research
Foundation
111 East 59th Street, 11th floor
New York, NY 10022-1202
www.crf.org
142
CRF is a global leader at the forefront of
10_11_12_13_14AATS15_Mon.indd 11
today’s treatments and technologies in the
fight against heart disease. Since its inception in 1991, CRF has played a pivotal
role in advancing the understanding and
treatment of cardiovascular disease, realizing dramatic improvements by establishing
the safe use of new technologies, drugs, and
therapies in the field of interventional cardiovascular procedures.
ClearFlow, Inc.
809
1630 S. Sunkist St., Suite E, Anaheim, CA
92806
www.clearflow.com
The PleuraFlow® Active Clearance Technology™ System from ClearFlow, Inc. offers
a safe way to proactively prevent clot from
accumulating in a completely sterile system,
thus minimizing Retained Blood Syndrome
(RBS) complications that can result from
ineffective evacuation of blood after surgery.
New! Distributed in the US by Maquet
Medical Systems.
Cormatrix Cardiovascular, Inc.
1327
1100 Old Ellis Road, Roswell, GA 30076
www.cormatrix.com
CorMatrix® Cardiovascular markets its
ECM® Bioscaffold devices for vascular
repair, pericardial repair and reconstruction, cardiac tissue repair, and CanGaroo
ECM Envelope and is currently conducting preclinical studies to evaluate future
applications in other cardio and vascular
applications.
Covidien
1123
555 Long Wharf Drive, New Haven, CT
06511
Covidien is a leading global healthcare
products company that creates innovative
medical solutions for better patient outcomes and delivers value through clinical
leadership and excellence. Please visit www.
covidien.com/surgical to learn more.
CRC Press - Taylor &
Francis Group LLC
1106
6000 Broken Sound Parkway NW., Suite 300,
Boca Raton, FL 33487
www.crcpress.com
CRC Press – Taylor & Francis Group is
a global publisher of print and electronic
books for medical, scientific and technical
communities. Visit our booth to browse
our new and bestselling publications in
cardiothoracic surgery and take advantage
of convention discounts. Register for email
alerts at www.crcpress.com.
CryoLife, Inc.
523
1655 Roberts Blvd NW., Kennesaw, GA 30144
www.cryolife.com
CryoLife® is one of the world’s leading
contemporary medical device companies
providing preserved human cardiac and
vascular tissues, surgical adhesives and
sealants, and cardiac lasers for treatment
of refractory angina. CryoLife® is committed to partnering with academic training
programs and cardiac surgical societies and
associations through their new Thoracic
Surgery Education Reform Initiative.
•
AATS 95TH ANNUAL MEETING 11
S EATTLE , WA
CTSNet
140
633 N. St Clair, Chicago, IL
www.ctsnet.org
CTSNet (www.ctsnet.org), headquartered
in Chicago, Illinois, USA, is the leading
international source of online resources
related to cardiothoracic surgery, as well as
the major hub of the international online
community of cardiothoracic surgeons and
allied health care professionals.
CureVentions
1312
595 N. Dobson Rd Suite B-32
Chandler, AZ 85224
www.cureventions.com.
Cure Ventions’ Sternal Vest is the only
compression vest designed specifically to
meet the needs of the cardiothoracic heart
patient. For more than a decade, we have
consistently delivered a superior quality
product with unsurpassed results--maintaining incision stability, reducing pain,
improving respiration, and quicker mobilization. With improved patient comfort,
prescribed therapies are more likely to
be followed. Nurses and surgeons attest
to the significant improvement Cure
Ventions’ Sternal Vest makes in patients
recovery.
De Soutter Medical USA
1324
224 Rolling Hill Road, Suite 12A, Mooresville,
NC 28117
www.de-soutter.com
DeSoutter Medical is a world leader in
orthopedic power tools. The Sternudrive
Cardiothoracic saw has a unique active
damping system that reduces vibration by
30%. Lithium Ion sterile battery technology assures a class leading power to weight
ratio and a wrench less micro adjustable
blade guard provides optimum control.
Designs For Vision, Inc.
431
760 Koehler Avenue, Ronkonkoma, NY, 11779
www.designsforvision.com
Just Se It™ with Designs for Vision’s lightweight custom-made surgical Telescopes
- See It Even Better™ with the L.E.D.
Daylite® or Twin Beam®, L.E.D. Daylite®
providing the brightest and safest un-tethered illumination. Introducing the L.E.D.
Daylite® Nano Cam HD video from your
prospective.
EACTS
128
EACTS House, Madeira Walk Windsor, SL4
1EU, United Kingdom
www.eacts.org
EACTS is the largest European Association
devoted to the practice of Cardio-thoracic
surgery. The main objective of the Association is to advance education in the field of
cardio-thoracic surgery and to promote, for
the public benefit, research into cardiovascular and thoracic physiology and therapy and
to correlate and disseminate the useful results
thereof. Visit booth 124 for information on:
membership, future meetings and all activities of EACTS. Journals: EJCTS (European
Journal of Cardio-Thoracic Surgery) ICVTS
(Interactive Cardiovascular and Thoracic
Surgery) and MMCTS (Multimedia Manual of Cardiothoracic Surgery).
Edwards Lifesciences
737
One Edwards Way, Irvine, CA 92614
www.edwards.com
Edwards Lifesciences is the global leader
in the science of heart valves and hemodynamic monitoring. Driven by a passion to
help patients, the company partners with
clinicians to develop innovative technologies in the areas of structural heart disease
and critical care monitoring, enabling them
to save and enhance lives. Additional company information can be found at www.
edwards.com.
Elsevier Inc.
508
1600 JFK Blvd., Ste 1800, Philadelphia, PA
19103
www.elsevierclinicalsolutions.com
ELSEVIER is a leading publisher of
health science publications, advancing
medicine by delivering superior reference information and decision support
tools to doctors, nurses, health practitioners and students. With an extensive
media spectrum — print, online and
handheld, we are able to supply the
information you need in the most convenient format.
Enova Illumination
1326
1839 Buerkle Road, St. Paul, MN 55110
http://www.enovaillumination.com
Introducing Enova’s newest and brightest
LED surgical headlight, model XLT-225.
It is designed for deep cavity surgery and is
the brightest LED surgical headlight in the
world!5 year warranty on LED. Made in
USA since 2005.
ESTS
144
1 The Quadrant, Exeter, Devon, ex2 4le,
United Kingdom
www.ests.org
ESTS is the largest international general
thoracic surgery organization with over
1350 members from all Continents. Our
mission is to improve quality in our specialty: from clinical and surgical management
of patients to education, training and credentialing of thoracic surgeons worldwide.
ETHICON
904
190 Lexington Road, Glastonbury, CT 06033
www.ethicon.com
Ethicon US LLC , a Johnson & Johnson
company, commercializes a broad range of
innovative surgical products, solutions and
technologies used to treat some of today’s
most prevalent medical issues, such as:
colorectal and thoracic conditions, women’s
health conditions, hernias, cancer and obesity. Learn more at www.ethicon.com, or
follow us on Twitter @Ethicon.
Fehling Instruments GmbH
& Co. KG
331
Hanauer Landstr. 7A, 63791, Karlstein,
Germany
www.fehlingsurgical.com
FEHLING SURGICAL INSTRUMENTS features Minimally Invasive Valve
Sets including NEW Retractor designs for
unmatched Atrial Exposure. Stop by and
take our new MICS Simultator for a spin
Continued on page 12
4/26/2015 6:04:21 PM
12 AATS 95TH ANNUAL MEETING
Continued from page 11
to refine your manual/tactile skills on a
“Dummy”! CERAMO® surface means high
efficiency through enhanced performace,
increased endurance and minimal maintenance.
G & N Medical
1308
Maydwell Ave, Off Stane St., Horsham, United
Kingdom
www.gandn.com
G+N Medical is a British medical device
company which was established in 1974
originally selling laboratory consumables.
Today they are the UK market leaders
in DVT prevention and have a range of
specialist cardiothoracic products. G+N is
an independent company which is proud to
supply the highest quality, best value products to customers around the world.
Genesee BioMedical, Inc.
711
700 West Mississippi Avenue, Denver, CO
80223-3408
www.geneseebiomedical.com
Design Beyond Standard. Genesee BioMedical, Inc. provides unique devices for
cardiothoracic surgery including sternal/
thoracic valve retractors for adult, adult
congenital and pediatric cardiac surgery,
instruments for MICS, coronary graft
markers, suture guards, retraction clips and
aortic valve repair. Now available “PHOTOFIX” Bovine Pericardial Patch. Denver, CO USA www.geneseebiomedical.com.
Gore & Associates, Inc. 1008
1505 N. Fourth Street, Flagstaff, AZ 86004
www.goremedical.com
At Gore, we have provided creative therapeutic solutions to complex medical problems for more than 35 years. During that
time, more than 35 million innovative Gore
Medical Devices have been implanted,
saving and improving the quality of lives
worldwide. Our extensive family of products includes vascular grafts, endovascular
and interventional devices, surgical meshes
for hernia and soft tissue reconstruction,
staple line reinforcement materials, and
sutures for use in vascular, cardiac, and
general surgery. We are one of a select few
companies to appear on all of the US “100
Best Companies to Work For” lists since
the rankings debuted in 1984. For more
information, visit www.goremedical.com.
Hawaiian Moon
1313
321 S. Missouri Ave., Clearwater, FL 33756
Heart Hugger/Gen’l Cardiac
Technology
704
6489 Comden Ave. #106, San Jose, CA 95120
www.hearthugger.com
Heart Valve Society
132
500 Cummings Center, Suite 4550, Beverly,
MA 01915
www.HeartValveSociety.org
An International Heart Team. Leaders in
Evaluation, Management and Research.
HeartWare, Inc
910
500 Old Connecticut Path, Framingham, MA
01701
www.heartware.com
10_11_12_13_14AATS15_Mon.indd 12
A PRIL 25-29, 2015
HeartWare is dedicated to delivering
safe, high-performing and transformative
therapies that enable patients with heart
failure to get back to life. The company’s
breakthrough innovations begin with the
HVAD® Pump, designed to be implanted
in the pericardial space avoiding the more
invasive surgical procedures required with
older LVAD technologies. The HVAD
Pump is commercially available around
the world.
Integrated Sensing Systems
1205
391 Airport Industrail Dr., Ypsilanti, MI 48198
www.mems-issys.com
Integrated Sensing Systems, Inc. (ISS) is
a technology company that has built and
maintained a state of the art manufacturing
facility that supplies innovative MEMS
based solutions to each of its independent
business units to empower the business units
to deliver breakthrough products that are focused on both large and emerging markets.
International BioPhysics
Corporation
1110
2101 E. Elmo St. Suite 275, Austin, TX 78744
www.biophysicscorp.com
SternaSafe is an active adjustable stability
sternum support brace (patents pending)
which give patients hand-free mobility.
The SternaSafe is made from comfortable,
soft, breathing materials developed for sternotomy patients. The brace is worn by the
patient after their sternotomy operation.
The SternaSafe can be worn during their
hospital stay and subsequently at home.
The average use time at home is 21 days.
International Society of Minimally
Invasive Cardiac Surgery
1311
500 Cummings Center, Suite 4550, Beverly,
MA 01915
www.ismics.org
ISMICS: Innovation, Technologies, and
Techniques in Cardiothoracic and Cardiovascular/Vascular Surgery. 2015 ISMICS
Annual Scientific Meeting, 3-6 June 2015,
InterContinental Hotel, Berlin, Germany
www.ismics.org.
Intuitive Surgical, Inc.
723
•
W ASHINGTON S TATE C ONVENTION C ENTER
Kapp Surgical Instrument Inc.
512
4919 Warrensville Center Road, Cleveland,
Ohio 44128
www.kappsurgical.com
Kapp Surgical is a custom design shop which
designs surgical instruments and implants,
manufactures them, and sells as well as
distributes domestically and internationally.
Kapp’s exclusive products are: The Cosgrove
Heart Retractor, Strip T’s surgical organizer,
and countless surgical devices all FDA approved with several pending approvals.
Karl Storz EndoscopyAmerica, Inc.
604
2151 E. Grand Ave., Suite 100, El Segundo, CA
90245
www.karlstorz.com
KARL STORZ, a leader in endoscopic
technologies for over 70 years, offers solutions for video-assisted thoracic surgery.
Among our mediastinoscopy products is
the SLIM Distending Mediastinoscope, an
ideal solution for advanced procedures at
the mediastinum. Our EndoCAMeleon®
Laparoscope enables surgeons to adjust the
scope’s viewing direction from 0° to 120°.
KLS Martin, LP
705
PO Box 16369, Jacksonville, FL 32245
www.klsmartinnorthamerica.com
KLS-Martin, a responsive company, is
focused on the development of innovative
products for oral, plastic and craniomaxillofacial surgery. New product developments in our titanium osteosynthesis
plating systems allow these products to be
used for rapid sternal fixation and reconstruction.
Lara Tape Labs, LLC
1211
8777 N. Gainey Center Drive, Suite 136,
Scottsdale, AZ 85258
www.laratapelabs.com
Lara Tape Labs is a designer and manufacturer of high performance expanded
PTFE films and membranes designed to
solve medical applications.
LifeNet Health
810
1864 Concert Dr. Virginia Beach, VA 23453
www.lifenethealth.org
Intuitive Surgical is the global leader in minimally invasive, robotic-assisted surgery. Its
da Vinci® Surgical System – with a 3D-HD
vision system and EndoWrist® instrumentation – enables surgeons to offer a minimally
invasive approach for a range of complex
procedures. da Vinci is used in more than
2,500 hospitals around the world.
LifeNet Health helps save lives, restore
health, and give hope to thousands of patients each year. We are the world’s most
trusted provider of transplant solutions,
from organ procurement to new innovations in bio-implant technologies and
cellular therapies—a leader in the field of
regenerative medicine, while always honoring the donors and healthcare professionals
that allow the healing process.
JACE Medical
LoupeCam by VizVOCUS inc.
1020 Kifer Road Sunnyvale, CA 94086
www.intuitivesurgical.com
1104
17020 Duck Lane, Haymarket, VA 20169
www.jacemed.com
JACE is a medical device development
company pioneering a fully integrated,
re-sequencing technology + application for
sternal resection and closure. We innovate
with an eye toward providing definitive
benefits across the entire five-sided healthcare spectrum of Patient, Physician, Provider, Payer and Regulator.
1225
10245 E. Via Linda Blvd, Suite 210, Scottsdale,
AZ 85258
www.loupecam.com
The ProHD LoupeCam® takes visualization and HD video recording to a complete
different level. This nickel-size camera, with
only 0.4 oz, offers a 3.0 MP sensor, a builtin microphone and HD video recording
1280x720p directly to your laptop with
full Mac or Windows options. Mounting
adapters available for all loupes models.
•
S EATTLE , WA
The Bluetooth Footpedals ensure a complete
hands-free experience. www.LoupeCam.com
LSI Solutions
1111
7796 Victor-Mendon Rd., Victor NY 14564
www.lsisolutions.com
COR-KNOT® delivers instant security
with automated knot placement and integrated suture trimming in one easy step.
COR-KNOT® may reduce cardiopulmonary bypass and cross-clamp time in your
OR. Visit LSI SOLUTIONS® at booth
1111 to learn more.
Magic Masseuse
1304
8056 17th Ave NE, Seattle, WA 98115
www.magicmasseuse.com
You have to try it, to believe it. Aching
back, neck pain, sore hips, knee or ankle
pain, sciatica, headaches, fibromyalgia,
blood circulation, plantar fascitis, arthritis, tennis elbow. Instant pain relief. Same
professional treatment you would get at the
doctor or chiropractor office. Easy to use,
safe and effective.
Mallinckrodt Pharmaceuticals
601
12481 High Bluff Drive #200, San Diego, CA
92130
www.mallinckrodt.com
Mallinckrodt is a global specialty biopharmaceutical and medical imaging business
that develops, manufactures, markets and
distributes specialty pharmaceutical products and medical imaging agents. Mallinckrodt is an industry leader in intravenous
analgesia for acute pain management. Visit
www.mallinckrodt.com to learn more.
MAQUET Medical Systems, USA 337
45 Barbour Pond Road, Wayne, NJ 7470
www.maquet.com
MAQUET Medical Systems is a market
leader focused on improving patient care
and quality of life. We offer a comprehensive
portfolio of innovative products designed
to meet the needs of clinical professionals in
the areas of: advanced hemodynamic monitoring, cardiothoracic and vascular surgery,
thoracic drainage, cardiac intervention, perfusion, anesthesia and ventilation.
MED Alliance Solutions, LLC
717
3825 Commerce Drive, St. Charles, IL 60174
www.medalliancesolutions.com
ISO 13485 certified medical device distributor committed to providing high quality
specialty devices for cardiothoracic surgery
worldwide. Exclusive US distributor of
French instruments manufacturer Delacroix-Chevalier and partner of Michigan
based Surge Cardiovascular for open heart
surgical products.
Medela, Inc.
1011
1101 Corporate Drive, McHenry, IL 60050
www.medela.com
Medela concentrates on two divisions:
“Breastfeeding”, leading in the development
and production of breastfeeding products, and “Healthcare”, engineering and
manufacturing highly innovative medical
vacuum technology solutions. Medela has
18 subsidiaries, distributes its products in
over 90 countries, and employs 1,500 staff
worldwide.
4/26/2015 6:04:21 PM
A PRIL 25-29, 2015
•
W ASHINGTON S TATE C ONVENTION C ENTER
Medistim
517
14000 25th Ave. N. Ste. 108, Plymouth, MN
55447
www.medistim.com
Medistim is the standard of care in the operating room. With the unique combination
of transit time flow measurement (TTFM)
and high frequency ultrasound imaging
guidance to help reduce and minimize the
risk of negative postoperative outcomes,
Medistim’s quality assessment technology
offers surgeons quantifiable validation and
guidance during cardiovascular, vascular,
transplantation and neurosurgery.
Medtronic, Inc.
537
710 Medtronic Parkway MS-LS290,
Minneapolis, MN 55432
www.medtronic.com
602
PO Box 1378, Bellaire, TX, 77402
www.microsurgeryusa.com
Microsurgery Instruments is one of the
leading suppliers of surgical instruments
and loupes. Our instruments include:
titanium scissors, needle holders, and
debakey forceps. Our Super-Cut scissors
are the sharpest in the market, and our
newly designed surgical loupes offer up
to 130mm field of view, and up to 11x
magnification.
MT Medi Corp.
1227
2207-33 Wood Street, Toronto, ON M4Y 2P8,
Canada
www.mtmedi.com
We offer Exceptional Spring Style and
Double Action Titanium Scissors, Forceps and Needle Holders with Tungsten
Carbide Inserts for Thoracic and Cardan
Surgery. We guarantee 20,000 cuts for our
Titanium Scissors and 5 years warranty
for Titanium Forceps and Titanium Needle
Holders with excellent grasping. Free of
charge Trial available.
Myriad Genetic Laboratories
611
320 Wakara Way, Salt Lake City, UT 84108
www.myriad.com
Myriad Genetics is a leading molecular
diagnostic company dedicated to making a
difference in patients’ lives through the discovery and commercialization of transformative
tests to assess a person’s risk of developing disease, guide treatment decisions and assess risk
of disease progression and recurrence. Myriad’s portfolio of molecular diagnostic tests are
based on an understanding of the role genes
play in human disease and were developed
with a commitment to improving an individual’s decision making process for monitoring
and treating disease. Myriad is focused on
strategic directives to introduce new products,
10_11_12_13_14AATS15_Mon.indd 13
NeoChord, Inc.
811
7700 Equitable Drive, Suite 206, Eden Prairie,
MN 55344, USA
www.neochord.com
NeoChord, a U.S.A. medical device company, has developed a new minimally invasive technology that enables beating heart,
sternal sparing implantation of artificial
chord tendinae, for the treatment of degenerative mitral valve regurgitation. CE mark
was obtained in December, 2012, and
more than 200 patients have been treated
to date.
On-X Life Technologies, Inc.
At Medtronic, we’re committed to Innovating for life by pushing the boundaries of
medical technology and changing the way
the world treats chronic disease. Medtronic’s breadth of solutions in structural heart
and aortic disease management includes:
tissue, mechanical and transcatheter valves;
irrigated RF and cryo surgical ablation
devices; aortic stent graft systems; and
OPCAB, MICS CABG, cannulae and perfusion products.
Microsurgery Instruments, Inc.
including companion diagnostics, as well as
expanding internationally.
730
1300 E. Anderson Lane, Bldg. B, Austin, TX
78752
www.onxlti.com
On-X® Life Technologies, Inc., Product
Description On-X® Heart Valves: Patented
natural design and On-X® Carbon offer
reduced turbulence in a mechanical valve
to rival the clinical and hemodynamic
performance of bioprostheses. FDA IDE
approved PROACT (Prospective Randomized On-X® Anticoagulation Clinical
Trial) is in process. Chord-X PTFE suture
is available for mitral valve repair.
Orascoptic
709
3225 Deming Way #190, Middleton, WI
53562
www.orascoptic.com
Orascoptic has been designing and manufacturing award-winning loupes, lights
and operator chairs for surgeons, dentists
and hygienists for more than 30 years. The
Orascoptic focus is superior visualization
coupled with oprimal clinical ergonomics.
We are recognized as the inovators in the
market, being the first company to bring
you a portable LED light, the first loupe
with a built-in cable-less headlight, and the
first loupe with adjustable magnification
(zoo) power.
Otto Trading, Inc.
1209
1921 Carengie Ave Suite C., Santa Ana, CA
92705
Manufacturer and distributor of hand-held
portable digital massager, TENS unit
Oxford University Press
808
198 Madison Ave., New York, NY 10016
Peters Surgical
831
42, Rue Benoit Frachon, Bobigny cedex,
93000, France
•
AATS 95TH ANNUAL MEETING 13
S EATTLE , WA
difference in minimally invasive treatment
to improve patient outcomes and save lives.
With our Live Image Guidance and Data
Integration Solutions we aim to remove
barriers to safer, more effective, and more
reproducible treatments, delivering relevant
clinical value where it’s needed most - at the
point of patient treatment.
Qualiteam s.r.l.
1016
Casale Nassio Sopra 15A, Chiaverano, TO,
10010, Italy
www.qualiteam.com
Founded by a nurse Qualiteam focuses
100% on advancing recovery through
prevention of complications after surgery
(infections, dehiscence, pain, respiratory
issues). Our unique wound support products are patented, FDA-cleared and reimbursable. The high performance is clinically
proven in even the worst, post-surgery scenarios. Visit our booth for details.
Quest Medical Inc.
909
One Allentown Pkwy., Allen, TX 75002
www.questmedical.com
Quest Medical, Inc. is a medical device
manufacturer and worldwide distributor
specializing in protecting the heart during
cardiac surgery with the Quest MPS 2®
and Microplegia. Quest also offers a unique
variety of aortic punches, safety valves, vascular loops, and an anesthesia line designed
for optimum cardiovascular surgery.
Rose Micro Solutions
1306
4105 Seneca Street, West Seneca, NY 14224
www.rosemicrosolutions.com
Rose Micro Solutions sells High Quality
Optical Loupes & LED Lights for Less! Our
Loupes start @ $279.00. We are a “Family”
Business consisting of 4 Brothers. We named
the company after our mother “ROSE”. Stop
by Booth # 1307 to see for yourself!
RTI Surgical Inc.
805
11801 Research Circle, Alachua, FL 32615
www.rtisurgical.com
RTI Surgical™ is a leading global surgical
implant company providing surgeons with
safe biologic, metal and synthetic implants.
Committed to delivering a higher standard,
RTI’s implants are used in sports medicine,
general surgery, spine, orthopedic, trauma
and cardiothoracic procedures and are distributed in nearly 50 countries.
Rultract/Pemco Inc.
700
5663 Brecksville Road, Cleveland, OH 441311593
Péters Surgical develops, manufactures and
distributes high-end medical devices worldwide. Vitalitec, the US subsidiary, will be
highlighting the CYGNET® flexible clamp,
Enclose II™ anastomosis assist device and
our Péters Surgical® CVT sutures. We will
also proudly display the Geister® brand instrumentation that we distribute in the US.
PemcoMedical LLC is an international
distribution company located in Cleveland,
Ohio that focuses on the design and manufacturing of precision Cardiovascular surgical instruments. Currently we represent
Pemco Inc., the Rultract “Skyhook” and
Sontec Instrument Company.
Philips Healthcare
One Scanlan Plaza, St. Paul, MN 55107
www.scanlaninternational.com
1023
22100 Bothell-Everett Highway, Bothell, WA
98021
www.usa.philips.com/healthcare
Philips Healthcare – Image Guided
Therapy Systems Together we make the
Scanlan International, Inc.
333
Highest quality surgical products designed and manufactured by the Scanlan
family since 1921. Over 3000 titanium
and stainless steel precision instruments
including: VATS/MIS thoracoscopic
instruments, Scanlan® SUPER CUT™
Scissors, and Scanlan® LEGACY titanium
needle holders and forceps. Single-use
products include Aorta/Vein Punches,
VASCU-STATT® bulldog clamps and graft
markers.
Siemens Healthcare
1117
51 Valley Stream Parkway, Malvern, PA 19355
www.healthcare.siemens.com
Siemens Healthcare helps providers meet
clinical, operational and financial challenges. A global leader in medical imaging,
laboratory diagnostics and IT, we understand the entire care continuum—from
prevention and early detection to diagnosis
and treatment. For more: usa.siemens.
com/healthcare
Sontec Instruments Inc.
505
7248 South Tucson Way, Centennial, CO,
80112
www.sontecinstruments.com
Sontec offers a comprehensive selection of
exceptional hand held surgical instruments,
headlights and loupes available to the discriminating surgeon. There is no substitute
for quality, expertise and individualized
service. Sontec’s vast array awaits your
consideration at our booth.
Sorin Group
343
14401 W. 65th Way, Arvada, CO 80004
www.sorin.com
Solo Smart Aortic Pericardial Tissue
Valve
The Solo Smart aortic pericardial tissue
valve is 100% pure tissue – free of stents,
suture rings and obstructions to blood flow.
Solo Smart has no synthetic material and
provides native-like performance.
Memo 3D ReChord Annuloplasty
Ring
With dynamic cell structure allowing true
physiological 3D motion, Memo 3D ReChord truly reflects the native mitral annulus. The addition of our innovative cordal
guide system makes artificial chordae replacement a more standardized procedure.
Spiration, Inc.
1005
6675 185th Ave NE, Redmond, WA 98052
www.olympusrespiratory.com
The Spiration® Valve System has a humanitarian device approval in the U.S. to
control specific post-operative air leaks of
the lung and has CE mark approval for
the treatment of diseased lung in emphysematous patients and for damaged lung
resulting in air leaks by limiting air flow to
selected areas.
St. Jude Medical, Inc.
931
6300 Bee Caves Rd., Austin, TX 78746
St. Jude Medical is dedicated to transforming the treatment of some of the world’s
most expensive epidemic diseases by creating cost-effective medical technologies that
save and improve lives of patients around
the world.
Stroke Prevention Systems
1200
27 Hoku Place, Paia, Maui, HI 96779
The Stroke Prevention System (SPS™) is
Continued on page 14
4/26/2015 6:04:21 PM
Continued from page 13
a patented technology based on external
carotid compression, creation of a pressure
gradient and deflection of cerebral emboli.
It is performed on demand when generation of cerebral emboli is anticipated. The
SPS™ device has been used successfully in
patients undergoing heart surgery.
STS
134
633 N. St Clair, Chicago, IL 60611
www.sts.org
The Society of Thoracic Surgeons represents
more than 6,900 cardiothoracic surgeons,
researchers, and allied health care professionals worldwide who are dedicated to
ensuring the best surgical care for patients
with diseases of the heart, lungs, and other
organs in the chest. The Society offers a
wide variety of member benefits, including
reduced participation fees in the renowned
STS National Database, a complimentary
subscription to The Annals of Thoracic
Surgery, clinical practice guidelines, dynamic educational offerings, online patient
information resources, and much more.
Stop by booth #134 or visit www.sts.org to
learn more.
STS Advocacy Center
136
20 F. St. NW, Washington, DC 20001
www.sts.org
Stop by STS Advocacy Center booth #136
where you can receive timely information
on federal legislative and regulatory initiatives impacting the specialty, obtain tools to
engage members of Congress, and become
a Key Contact for government affairs issues
in your district. STS members can also
contribute to STS-PAC and support champions of cardiothoracic surgery in Congress.
Surgitel/General Scientific Corp
907
77 Enterprise Drive, Ann Arbor, MI 48103
www.surgitel.com
SurgiTel is the manufacturer of premium
loupes and headlights sold around the
world from their headquarters in Ann
Arbor, Michigan. Holding a variety of pat-
ents, SurgiTel is always on the forefront of
Vision and Ergonomics.
SynCardia Systems, Inc.
605
1992 E Silverlake Drive, Tucson, AZ 85713
www.syncardia.com
The SynCardia temporary Total Artificial Heart (TAH-t) is the world’s only
FDA, Health Canada and CE approved
Total Artificial Heart. It is approved as
a bridge to transplant for patients dying
from end-stage biventricular failure. Visit
our booth for updates on the Freedom®
portable driver, 50cc TAH-t, and destination therapy.
Terumo Cardiovascular Group
531
6200 Jackson Road, Ann Arbor, MI 48103
www.terumo-cvs.com
Vascutek, a Terumo company, will display
Gelweave™ gelatin-sealed, woven and
branched vascular grafts. The Vascutek
CE-marked Thoraflex™ Hybrid device will
also be featured (Not cleared for sale in
the USA). Terumo will display the VirtuoSaph® Plus Endoscoipc Vessel Harvesting
System, Beating Heart and Surgical Stabilization products for cardiothoracic procedures, and Terumo® Perfusion Products.
Thompson Surgical Instruments,
Inc.
600
10170 East Cherry Bend Road, Traverse City,
MI 49684
www.thompsonsurgical.com
Thompson Surgical is a leader in exposure and the original manufacturer of the
table-mounted Thompson Retractor. In
cardiovascular surgery, surgeons will benefit from the Thompson Surgical Bolling
Retractor. The Bolling Retractor provides
extremely low profile, stable, and Uncompromised Exposure of the heart structures
for valve procedures.
Thoracic Surgery Foundation for
Research and Education
1309
633 N. St Clair, Chicago, IL 60611
www.tsfre.org
TSFRE was established in 1988 as a
Industry Sponsored
Symposia
Monday, April 27
5:00 p.m. – 7:30 p.m.
Patient Benefits of the On-X Aortic Valve at
INR 1.5 – 2.0.
Description: How reduced anticoagulation for a
mechanical heart valve benefits patients & changes
the risk benefit assessment of valve chance in aortic
valve replacement.
Supported by On-X
Monday, April 27
6:00 p.m. – 8:30 p.m.
Title: An evening of Clinical Discussion &
Hands-On experience.
Description: Clinical Discussion and hands-on wet
lab with the solo smart aortic tissue valve.
Supported by Sorin Group
10_11_12_13_14AATS15_Mon.indd 14
A PRIL 25-29, 2015
•
W ASHINGTON S TATE C ONVENTION C ENTER
501c(3) not-for-profit charitable organization by the four leading thoracic surgery
societies: AATS, STS, STSA, and WTSA.
TSFRE’s mission is to foster the development of surgeon scientists in cardiothoracic
surgery; increasing knowledge and innovation to benefit patient care.
Thoramet Surgical Products
1006
301 Route 17 N, Suite 800, Rutherford, NJ
7070
www.thoramet.net
Thoratec Corporation
520
6035 Stoneridge Drive, Pleasanton, CA 94588
www.thoratec.com
Thoratec is the world leader in mechanical circulatory support with the broadest
product portfolio to treat the full range of
clinical needs for patients suffering from
advanced heart failure. The company’s
products include the HeartMate LVAS and
Thoratec VAD, with more than 20,000
devices implanted in patients suffering from
heart failure.
Transonic Systems Inc.
706
34 Dutch Mill Rd., Ithaca, NY 14850
www.transonic.com
Transonic’s new ELSA® Extracorporeal
Life Assurance Monitor provides novel
quantification of recirculation in VV-ECMO, oxygenator blood volume for VA/VV
ECMO as well as Transonic’s gold standard flow measurement for CPB.
Vitalcor, Inc.
516
100 E. Chestnut Avenue, Westmont, IL 60559
www.vitalcor.com
Latex Free Coronary Artery Balloon Cannulae with self-inflating Balloon (3-year
shelf life). Reusable Dingo (Bulldog)
Clamp. Titanium and stainless steel specialty instruments and retractors. Reusable
stabilizer for Beating Heart Surgery and
Mitral Valve Retractor.
Wexler Surgical
•
S EATTLE , WA
www.wexlersurgical.com
Wexler Surgical designs and manufactures
a variety of titanium and stainless steel
specialty surgical instruments and products
for Cardiac, Vascular, Thoracic, and Micro Surgery. Come see our VATS/MICS
instruments and ask about our Optimus
Series. Visit us online at www.wexlersurgical.com for more information about our
products and the services.
Wolters Kluwer Health
501
2001 Market Street, Philadelphia, PA 19103
www.wolterskluwer.com
Wolters Kluwer is a leading publisher of
medical, health and science publications.
We offer an extensive selection of medical
books, journals, and electronic media for
doctors, nurses, specialized clinicians and
students. Please visit booth 501 to browse
our comprehensive product line.
WSPCHS
908
2300 Tupper Street Room C8-29, Montreal,
QC, H3H 1P3, Canada
The mission of the World Society for Pediatric and Congenital Heart Surgery is to
promote the highest quality comprehensive
cardiac care to all patients with congenital
heart disease, from the fetus to the adult,
regardless of the patient’s economic means,
with an emphasis on excellence in teaching,
research and community service.
ZipperBelt.com
1305
3419 Westminster #276, Dallas, TX 75205
The zipper belt Brace was developed for
patients who are now zipper club members.
Transient events such as coughing or sneezing or even pushing up from a chair can be
very painful. The zipper belt is a brace that
the patient can wear and at a moments
notice can get relief from a violent sneeze or
cough instead of just squeezing a pillow.
919
11333 Chimney Rock Road Suite #110,
Houston, TX 77035
Attendee Reception at the Museum of Flight
L
et your imagination take flight! The
AATS Annual Attendee Reception will
be held on Tuesday, April 28, from 7:00
p.m. to 10:00 p.m. at The Museum of Flight,
the world’s largest private air and space
museum. It has more than 150 aircraft in
its collection, including the famous Blackbird, the only remaining Boeing 80A, and
the Aerocar III. An new exhibit, Inspiring
Rockets, explores the influence model rocketry has had in shaping the lives of young
enthusiasts. Among the permenant exhibits
are NASA Apollo 17 Mission models, historic aircraft from the early days of flight,
World War I and World War II.
Tickets are $85.00 and available when
you register online or may be purchased
onsite at the Registration desk at the Convention Center.
GUROADRUNNER/ WIKIMEDIA. ORG
14 AATS 95TH ANNUAL MEETING
4/26/2015 6:04:56 PM
A PRIL 25-29, 2015
•
W ASHINGTON S TATE C ONVENTION C ENTER
•
S EATTLE , WA
AATS 95TH ANNUAL MEETING 15
New Product Launches in the AATS Exhibit Hall
Biomet Microfixation
804
RibFix Blu is a comprehensive thoracic fixation system that allows for the
stabilization and rigid fixation of fractures in the chest wall including sternal
reconstructive procedures, trauma or
planned osteotomies.
SternaLock Blu MICS is a Minimally Invasive Closure Solution for
mini-sternotomies. The instrumentation and rigid fixation combination
facilitate sternal approximation and
stabilization of the bony segments at
the time of closure.
CryoLife, Inc.
523
PhotoFix™ is a proven, clinically effective alternative to native pericardium
without any chemical modification,
providing a natural feel and handling
without cytotoxicity or mutagenic response. Ideal for:
• Pericardial Closure
• Atrial/Ventricular Repair
• Congenital Defects (ASD/VSD)
• Great Vessel Repair (Aortic Root,
Aortic Arch, LVOT)
Davol Inc. A BARD Company 617
PROGELTM Pleural Air Leak Sealant is now FDA approved for use in
Video-Assisted and Robotic-Assisted
Thoracic Surgery. Visit Bard BioSurgery Booth to learn more.
Enova Illumination
1326
Enova Illumination introduces the
world’s brightest LED surgical headlight – Cyclops XLT-225. It features
225,000 lux, pure white uniform illumination, 4-5 hour battery life, and
light weight for comfort.
Genesee BioMedical, Inc.
711
Now available! PhotoFix™ a tissue-engineered decellularized bovine pericardial patch prepared with dye-mediated
photofixation. No glutaraldehyde is
used in the manufacturing process.
Produced by Genesee BioMedical, distributed by CryoLife.
International Biophysics Corp. 1110
Introducing SternaSafe - SternaSfe is
an active adjustable stability sternum
support brace with locking lever for
hands free use. Simple pulley system
for adjustable sternum support after
sternotomy operation.
LoupeCam by VizVOCUS inc. 1225
LoupeCam® is the market leader in
head mounted HD surgical cameras
and now the only company offering cross platform compatibility
with the recent release of our Mac
software and Bluetooth foot pedal.
www.loupecam.com
On-X Life Technologies, Inc. 730
On-X Life Technologies is proud to announce FDA Approval to reduce INR
to 1.5–2.0 for On-X® Aortic Heart Valve
patients starting 3 months after surgery.
Rultract/Pemco Inc.
700
The NEW Rultract Skyhook Retractor / SPREADER device improves
the direct visualization and tunnel
creation by lifting the sternum and
spreading the sternum as the adhesions are cut away.
Scanlan International, Inc.
333
New VATS / MICS Instruments:
• Chitwood Aortic Clamp for MiniAVR procedures.
• D’Amico Biopsy Forceps, shorter,
finer shaft.
• Gonzalez-Rivas Dissector, fine tip.
• Gonzalez-Rivas Lung Grasper, high
tension.
• Foerster Clamp, 25x35 mm oval ring
jaws.
• Foerster Clamp, 5 mm tapered shaft
New SCANLAN® Dennis 2x3 DeBakey Clamps.
Sorin Group
343
Solo Smart Aortic Pericardial Tissue Valve
The Solo Smart aortic pericardial
tissue valve is 100% pure tissue – free
of stents, suture rings and obstructions to blood flow. Solo Smart has
no synthetic material and provides
native-like performance.
Memo 3D ReChord Annuloplasty Ring
With dynamic cell structure allowing
true physiological 3D motion, Memo
3D ReChord truly reflects the native
mitral annulus. The addition of our
innovative cordal guide system makes
artificial chordae replacement a more
standardized procedure.
Thompson Surgical Instruments 600
Introducing the Drake Hook from
Thompson Surgical Instruments:
Improved chord lysis and division of
rheumatic tissue, rapid measurements,
and enhanced subvalvular exploration
for restrictive tissue.
Transonic
706
Transonic’s new ELSA® Extracorporeal
Life Assurance Monitor provides novel
quantification of recirculation in VV-ECMO, oxygenator blood volume for VA/
VV ECMO as well as Transonic’s gold
standard flow measurement for CPB.
Graham Foundation Fellowship Honors Marc R. de Leval
I
n 2013, the AATS Graham Foundation established the “Honoring
Our Mentors” Fellowship Program
to honor eminent cardiothoracic
and thoracic surgeons. The Marc de
Leval Fellowship is the second in the
series, which recognizes physicians
who have demonstrated longstanding
leadership and dedication throughout their careers in both their clinical
practices and their commitment to
training the future generation. The F.
Griffith Pearson Fellowship was the
first.
The AATS Graham Foundation —
the philanthropic arm of the American Association for Thoracic Surgery
(AATS) — is committed to leadership,
learning and innovation in cardiothoracic (CT) surgery. It serves this goal
through an impressive roster of more
than 20 programs — including the
“Honoring Our Mentors” Fellowships
— helping to ensure the present and
future strength of the specialty.
The Foundation’s training and scholarship opportunities make a difference
at every level of a CT surgeon’s development — expanding the knowledge
and skills of medical students, residents, fellows, recent graduates and
practicing surgeons.
15AATS15_Mon.indd 15
Marc R. de Leval Fellowship
About: Currently, there is only limited
funding available for North American
surgeons to receive specified training at
international congenital heart surgery
centers. Launching in 2016, the de
Leval Fellowship
will give young
North American
trainees and early
career congenital
heart surgeons
the opportunity
to spend four (4)
to six (6) weeks
studying congenDR. DE LEVAL
ital CT surgery
techniques at UK/
European institutions. Awardees will
receive a $5,000 stipend to help cover
travel and living costs while abroad.
The Mentor: For over 40 years,
Marc de Leval has practiced pediatric
cardiothoracic surgery in London.
Throughout that time, he has had a
close association with the AATS, starting with his two-year time as a Graham
Traveling Fellow (1973-1974). AATS
has recognized de Leval’s contributions to the organization by naming
him Annual Meeting Honored Guest
Lecturer and the recipient of the 2011
Scientific Achievement Award. Retired
from Britain’s National Health Service
(NHS), today de Leval is a Consultant
Cardiothoracic Surgeon at the Harley
Street Clinic and Professor of
Cardiothoracic Surgery at the
University of London.
F. Griffith Pearson
Fellowship
About: Created in 2013, the
Pearson Fellowship supports
surgeons who have finished
their residencies to advance their clinical thoracic techniques at a North
American host institute. Each fellow
receives $3,500
to defray living
expenses during
four (4) to six (6)
weeks of training. The first two
awardees were
named in 2014.
The Mentor: F.
Griffith Pearson
DR. PEARSON
practiced thoracic
surgery at Toronto General Hospital from 1950-1999.
Considered one of the fathers of modern tracheal surgery, he was AATS’s
79th President. Under his leadership,
University of Toronto established a
separate division of thoracic surgery
in 1968. Pearson introduced mediastinoscopy to North America in the early
1960s and demonstrated the
importance of mediastinal staging for lung cancer, which led to
a more rational approach to the
diagnosis, staging and treatment
of the disease. After retirement,
Pearson continued to pioneer
as a “surgeon in residence” in
Boston and Pittsburgh. Many say
that his greatest contribution to thoracic surgery over 50+ years has been
his influence on generations of young
surgeons who have become thoracic
surgery leaders around the world.
Transforming Lives of Patients
Today & Tomorrow
Every day, CT surgeons transform the
lives of their patients. The “Honoring
Our Mentors” Fellowship Program is
investing in the next generation of CT
surgeons, so that they will continue
doing so tomorrow. Learn more about
how you can invest in the future by
supporting one or both of these fellowships. Visit http://aatsgrahamfoundation.org/support-foundation.cgi or stop
by the AATS Welcome Center.
4/26/2015 6:13:01 PM
16 AATS 95TH ANNUAL MEETING
A PRIL 25-29, 2015
•
W ASHINGTON S TATE C ONVENTION C ENTER
•
S EATTLE , WA
Pulmonary Atresia at Saturday’s Congenital Heart Skills Course
I
n Saturday’s Congenital Heart Disease Skills Course, Frank L. Hanley,
MD, Stanford University, opened a
discussion of pulmonary atresia with a
presentation titled: “PA/VSD/MAPCAs
– Technique for Early Complete Repair.
He advised unifocalization as the primary repair strategy.
As part of the focus of his talk, Dr.
Hanley spent time emphasizing that the
MAP collaterals were viable for use if
used early in development after birth,
but that they deteriorated over time,
not because of intrinsic instability, but
because of the stressful environment in
which they found themselves due to the
pulmonary problems. So timing is very
critical in managing these collaterals.
Another factor supporting early
intervention is the fact that the pulmonary artery, if not provided with
improved circulation, will not grow
with the patient, which will lead to additional stress.
“All isolated collaterals in our protocol get unifocalized; dual-supply col-
Frank L. Hanley, MD, spoke on the
complications of pulmonary atresia.
laterals are more complex, and we will
unifocalize some and not others,” Dr.
Hanley summarized.
Yves d’Udekem, MD, said “one
operation does not fit all.”
“The point is to get every piece of
the distal bed,” he concluded.
Yves d’Udekem, MD, Royal Children’s Hospital, then discussed “Neonatal Pulmonary Artery Rehab without
Unifocalization.”
“We have been disappointed by the
translocation of the collateral arteries,”
he said, “and have adopted in the last
decade a policy of rehabilitation of the
native pulmonary arteries, including
much simpler procedures.
“We perform a central shunting of
the small native pulmonary arteries
in the first weeks of life and thereafter
force blood through this circulation by
repetitive procedures,” he said. “Simple
rehabilitation procedures suffice for a
large proportion of the patients,” Dr.
d’Udekem concluded.
The course chair was Eric H. Austin,
III, MD, University of Louisville.
A PRIL 25-29, 2015
A
•
W ASHINGTON S TATE C ONVENTION C ENTER
Congenital Heart Debates
Definitions, Origins, and Models
lively series of debates moderated by
Robert Jaquiss, MD, Duke University,
and Thomas L. Spray, Children’s Hospital of Philadelphia, launched Sunday’s
Congenital Heart Disease Symposium.
Topics featured whether neonatal stenosis
was a surgical disease; whether the anomalous origin of a coronary artery is always
a surgical disease and whether larger centers produced better outcomes in pediatric
cardiac surgery, with regionalization being
a superior model.
Charles D. Fraser, MD, argued that
regionalization is the best model.
This latter was debated by Charles D.
Fraser, MD, Texas Children’s Hospital
(Pro), and Mark Danton, MD, Royal Hospital for Sick Children, Glasgow (Con).
The topic is especially important in an era
when surgical quality and outcomes have
increasingly been shown to be tied to case
load, the availability of the equipment
and the use of highly trained support staff.
Case number is a particularly difficult
issue in congenital heart surgery, with its
numerous rare conditions.
Mark Danton, MD, stated that size alone
is not the best quality measure.
AATS
CARDIOVASCULAR
VALVE
SYMPOSIUM
2015
SAVE THE DATE
•
AATS 95TH ANNUAL MEETING 17
S EATTLE , WA
In-Booth Presentations
Intuitive Surgical
#723
Monday
9:05 a.m.
First Clinical Experience with the
da Vinci Endowrist® Stapler for
General Thoracic Surgical Procedures
Michael Zervos, MD, NYU
Langone Medical Center
12:15 p.m.
Delivering Reproducible Minimally Invasive Outcomes: Across a
Spectrum of Pulmonary Resection
Jeffery Hagen, MD, USC Keck
School of Medicine
3:20 p.m.
Robotics for Complex Pulmonary Resection: Lobectomy
Following Neoadjuvant Chemoradiation
Bernie Park, MD,
Memorial Sloan Kettering
Tuesday
10:05 a.m.
da Vinci Mitral Valve Repair: The
NYU Experience
Didier Loulmet, MD, and Eugene
Grossi, MD, NYU Langone
Medical Center
Live Tissue Demonstrations for
General Thoracic Procedures
Monday
9:30 a.m.
Michael Zervos, MD
12:34 p.m.
Jeffrey Hagen, MD
Spiration Valve System #1005
Monday
9:00 a.m. – 9:45 a.m.
Michael F. Reed, MD, and
Jennifer W. Toth, MD, Penn State
University
12:15 p.m. – 1:15 p.m.
Pierre Theodore, MD, UCSF
3:00 p.m. – 3:34 p.m.
Michael F. Reed, MD, Jennifer W.
Toth, MD, Penn State University
Tuesday
10:00 a.m. – 10:45 a.m.
Michael F. Reed, MD, and
Jennifer W. Toth, MD, Penn State
University
12:30 p.m. – 1:15 p.m.
Pierre Theodore, MD, UCSF
AMERICAN ASSOCIATION
FOR THORACIC SURGERY
We Model Excellence
COURSE DIRECTORS
David H. Adams
Mount Sinai School of Medicine
New York, New York, USA
Joseph S. Coselli
Baylor College of Medicine
Houston, Texas, USA
Walter J. Gomes
Federal University of São Paulo
São Paulo, Brazil
Pedro J. del Nido
Boston Children’s Hospital
Boston, Massachusetts, USA
Thoralf M. Sundt, III
Massachusetts General Hospital
Boston, Massachusetts, USA
November 20 - 21, 2015
Renaissance Marriott São Paulo
São Paulo, Brazil
www.aats.org/valvebrazil
18 AATS 95TH ANNUAL MEETING
A PRIL 25-29, 2015
•
W ASHINGTON S TATE C ONVENTION C ENTER
•
S EATTLE , WA
Coping with CABG at AATS/STS Adult Cardiac Surgery Symposium
I
n a presentation clearly of importance to cardiac surgeons, A. Pieter
Kappetein, MD, Erasmus Medical
Center, spoke on “When Is CABG
Clearly Superior to PCI?” in Sunday’s
AATS/STS Adult Cardiac Surgery
Symposium.
“Last year we celebrated the 50th
anniversary of coronary bypass
surgery,” said Dr. Kappetein, while
balloon angioplasty quickly followed
in 1977. Since then there has been
debate as to which procedure is clearly
superior, and many trials have taken
place to examine this over the years,
even into the present. Bare metal stents
then evolved, leading to new clinical
trials in comparison to CABG. Early
results showed that CABG and stenting were not significantly different in
mortality, said Dr. Kappetein, but this
was likely due to the fact that many of
these patients had one and two-vessel
disease, for which PCI is quite a good
alternative, and those with three-vessel
disease were highly amenable to PCI.
Drug-eluting stents were then introduced, and many cardiologists
were convinced that this was the end
of CABG, because the issue of repeat
revascularization was tackled. Of particular interest is the Syntax trial, in which
a heart team was assigned, involving
both a surgeon and a cardiologist, to determine whether a patient could be ran-
Clifford W. Barlow, MD, addressed how
to maintain quality in a CABG program.
A. Pieter Kappetein, MD, spoke on
when to use CABG as opposed to PCI.
Bruce W. Lytle, MD, discussed the use
of bilateral and sequential ITA grafts.
domized. At 4.5, the number of lesions
in those randomized in the Syntax trial
was much higher than those of other
trials – meaning that they had quite extensive coronary artery disease. In those
patients with three-vessel disease in the
study, “death was clearly different in PCI
versus coronary bypass surgery, in favor
of surgery,” Dr. Kappetein said.
Guidelines now favor coronary bypass
surgery for complex coronary artery disease, especially for those with a high Syntax score, Dr. Kappetein concluded.
“When we say ‘how many arterial
grafts,’ we know that we should use the
left IMA,” said Bruce W. Lytle, MD,
Cleveland Clinic, in his presentation,
“CABG and Arterial Grafts: How
Many Is Enough?”
“Since only 5% of patients in America receive more than one arterial graft,
if we just did a second ITA graft to
the second most important left-sided
vessel a lot of the time, that would be
a tremendous improvement,” Dr. Lytle
said. “It’s not necessary to get too fancy
to make things substantially better.”
However, he did point out that real
bypass surgery on a complex level is a
specialty, not like doing simple bypass.
“These are not slam-dunk operations,”
he said. “If we are not prepared to do
six arterial grafts to somebody, then we
probably shouldn’t do it, because we
stand a good chance of making things
worse rather than making things better,” Dr. Lytle added. “But we also have
a responsibility to prepare ourselves to
do those operations,” he concluded.
Clifford W. Barlow, MD, Southampton General Hospital, discussed “How
to Maintain Outcomes and Quality in
CABG.” Among his take-home messages was that outliers in quality should
be assisted and not punished, and that
constant research and innovation were
required to keep making improvements.
This year’s Adult Cardiac Skills
course was co-chaired by A. Marc Gillinov, MD, Cleveland Clinic, and Robert
Dion, MD, Ziekenhuis Oost-Limburg.
Gladiators Vied at AATS/STS General Thoracic Surgery Symposium
N
ot just debates, but “gladitorial
contests” were a feature of Sunday’s AATS/STS General Thoracic
Surgery Symposium, co-chaired by
Gail E. Darling, MD, Toronto General
Hospital, and Gaetano Rocco, MD, National Cancer Institute.
Each pair of ‘combatants’ was confronted with a series of case slides,
which they voted on (with the audience) as to appropriate treatment,
before launching into the fray with
their own presentations.
Facing off in a discussion of whether
“Wedge Resection Is a Palliative Procedure for Lung Cancer,” were Thomas
A. D’Amico, MD, Duke University, and
Douglas E. Wood, MD, University of
Washington.
The question of whether “SBRT
and Wedge Resection Are Equivalent
Therapies for Early-Stage Lung Cancer
and Oligometastatic Disease,” was the
focus of the debate by David C. Rice,
Gladiators Thomas D’Amico, MD, and Douglas Wood, MD, faced off on the issue
of the value of wedge resection.
MD, MD Anderson Cancer Center,
and Scott J. Swanson, MD, Brigham
and Women’s Hospital. The audience
consensus after the debate as determined by vote was that SBRT was not
equivalent to wedge resection.
Because SBRT exists on the competitive horizon whether surgeons like
it or not, there is a need to deal with
it. In “Surgeons and SBRT: How to
Incorporate SBRT Into Your Practice,”
Stephen R. Hazelrigg, MD, Southern
Illinois University, outlined the present standard of care with regard to the
role of SBRT and how the surgeon
should be involved.
“Presently both thoracic surgeons
and radiation therapists agree that
good operative risk patients with early-stage lung cancers should undergo
lobectomy and that nonoperative
patients should be treated with SBRT.
However there is a large group of
Continued on page 19
David C. Rice, MD, and Scott J. Swanson, MD, debated the equivalence of SBRT
to wedge resection.
A PRIL 25-29, 2015
•
W ASHINGTON S TATE C ONVENTION C ENTER
Continued from page 18
patients that are at higher risk for
surgery than the standard population.
Often these patients are deemed not
operative candidates without a surgeon evaluating them,” Dr. Hazelrigg
said.
In fact, only a cardiothoracic surgeon is in a real position to determine
whether a patient is authentically inoperable or not, and thus not a lobectomy
candidate. As this has not been the
case in many reported studies, the as-
THE OFFICIAL
NEWSPAPER
OF THE
Stephen R. Hazelrigg, MD, discussed
how to deal with the rise of SBRT.
AATS
•
S EATTLE , WA
AATS 95TH ANNUAL MEETING 19
signment of patients to the ‘inoperable‘
category in some of these instances
may be inaccurate.
Overall, he pointed out that data are
not as clear as to whether surgery that
is less than lobectomy, such as wedge
resection or segmentectomy, is superior to SBRT.
He also reviewed the pros and cons
for treating high-risk patients that cannot tolerate a lobectomy, emphasizing
that good surgical outcomes and use
of minimally invasive techniques are
necessary to treat the higher-risk patients and that the ideal is to present
these patients in multidisciplinary
conferences for discussion on the
choice of approach.
®
Serving the cardiothoracic community since 2005 with news, features,
and expert analysis from the United States and around the world.
DAILY NEWS
The Official Newspaper of the
AATS 95th Annual Meeting
AATS Staff
Executive Director
Cindy VerColen
Managing Editor
Lorraine M. O’Grady
FMC SOCIETY PARTNERS
PUBLICATION STAFF
Read our Print, Interactive app
and Digital Edition!
Vice President/Group Publisher;
Director, FMC Society Partners
Mark Branca
Advertising Sales
Artie Krivopal
Publication Editors
Therese Borden, Mark Lesney
Associate Editor
Gwendolyn B. Hall
Design Supervisor
Elizabeth Byrne Lobdell
Photographers
Nationwide Photographers
Production Specialist
Maria Aquino
Copyright 2015, American
Association for Thoracic Surgery,
500 Cummings Center, Suite 4550,
Beverly, MA 01915. Produced and
distributed for AATS by Frontline
Medical Communications. All rights
reserved. No part of this publication
may be reproduced or transmitted in
any form, by any means, without prior
written permission of the AATS. The
opinions expressed in this publication
are those of the presenters and
authors, and do not necessarily reflect
the views of the Association.
Cover photo: istock.com
Follow us on Twitter (@ThoracicTweets) and like us on Facebook.
www.thoracicsurgerynews.com
Maquet is a registered trademark of Maquet GmbH • Copyright Maquet Medical Systems USA or its affiliates.
CAUTION: Federal (US) law restricts this device to sale by or on the order of a physician. Refer to Instructions
for Use for current indications, warnings, contraindications, and precautions. MCV00027097 REVB
Beating heart surgery
has a rhythm all its own.
With OPCAB, the
rhythm of life never stops.
According to the 2004 ISMICS Consensus, keeping the heart beating during surgery has
been shown to be a safe alternative in reducing complications and mortality in patients
with surgical risk factors.
The top 8 reasons to consider Beating Heart Surgery may include less myocardial
injury3, shorter ICU times and reduced hospital stays3,4, lower mortality in high risk
patients2,reduced blood loss and need for transfusions1,4, lower rates of post-op renal
dysfunction/kidney failure1,reduced potential for early neurocognitive dysfunction1, and
reduced potential for sternal wound infection3,4.
1. Sellke FW, DiMaio JM, et al. Circulation. 2005 May 31;111(21):2858-64.
2. Lemma MG, Coscioni E, Tritto FP, et al. J Thorac Cardiovasc Surg. 2012
Mar;143(3):625-31.
3. Puskas JD, Williams WH, Duke PG, et al. J Thorac Cardiovasc Surg. 2003
Apr;125(4):797-808.
4. Ascione R, Angelini GD, et al. Eur Heart J. 2003;24:121-124.
Scan to learn more
about the advantages
of Beating Heart Surgery.
www.offpump.com
Maquet is proud to have partnered with our customers to reinforce our commitment to patients by supporting Make-A-Wish® with a donation in the amount of $150,000 to help fulfill the wishes
of children with life-threatening medical conditions across the USA. For more information about Make-A-Wish® visit wish.org.
At AATS 2015, visit Maquet at Booth #337
AATS Apr2015KingSz_OPCAB Rhythm Ad MCV00027097 REVB w MAW.indd 1
www.maquetusa.com
3/30/15 11:54 AM